|
Simtuzumab (INN; formerly GS 6624) is a humanized monoclonal antibody designed for the treatment of fibrosis.〔(Statement On A Nonproprietary Name Adopted By The USAN Council - Simtuzumab ), ''American Medical Association''.〕 It binds to LOXL2 and acts as an immunomodulator. == References == 〔 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Simtuzumab」の詳細全文を読む スポンサード リンク
|